Financial News
All news about Sanofi-Aventis S.A.
Genzyme's Lemtrada Approved in Canada for Treatment of MS
December 13, 2013
From Benzinga
Published Data, Stock Price Movements, and FDA Approvals - Research Report on Johnson & Johnson, Ariad Pharmaceuticals, PerkinElmer, BD, and Sanofi
December 13, 2013
From PR Newswire
4 ways to make Money off Washington next year
December 10, 2013
From CNBC.com News
FDA Grants Priority Review for Genzyme's Cerdelga for Gaucher Disease
December 10, 2013
From Benzinga
ImmunoGen to expand Waltham headquarters by 20 percent
December 10, 2013
From Business Journals
Sanofi US Launches Second Innovation Challenge: Collaborate | Innovate
December 09, 2013
From PR Newswire
Sundance Energy Corporation: Ochapowace 16-32-17-3W2M: Drilling Update
December 05, 2013
From Marketwired
From PR Newswire
From PR Newswire
The Multiple Sclerosis Association of America Announces Swim for MS - Why I Swim Campaign
December 04, 2013
From PR Newswire
Notable Two Hundred Day Moving Average Cross - SNY
December 03, 2013
Tags
Stocks
From Market News Video
Market Study: VIVUS, DENTSPLY Intl., Sanofi, and Healthways Inc.
December 03, 2013
From PR Newswire
From PR Newswire
CFO of Aveo to resign seven months after drug failure
December 02, 2013
From Business Journals
Alnylam gets $7M milestone from Genzyme for rare disease drug
November 27, 2013
From Business Journals
FDA Approvals, New Appointments, and Official Statements - Research Report on Pfizer, Aetna, Lilly, GSK, and Sanofi
November 27, 2013
From PR Newswire
Merrimack's stock rises on breast cancer data, new agreement
November 26, 2013
From Business Journals
Sanofi and Regeneron's Dupilumab Named "Clinical Advance of the Year" by Scrip Intelligence
November 24, 2013
From PR Newswire
Sundance Energy Announces Resignation of Director
November 22, 2013
From Marketwired
Sanofi, Regeneron Report Positive Results with Sarilumab in First Phase 3 Rheumatoid Arthritis Registration Trial
November 21, 2013
From Benzinga
Sanofi and Regeneron Report Positive Results with Sarilumab in First Phase 3 Rheumatoid Arthritis Registration Trial
November 21, 2013
From PR Newswire
Genzyme Convenes 5th Annual Gaucher Leadership Forum in Madrid
November 21, 2013
Health Canada Approves Genzyme's AUBAGIO® (teriflunomide), a Once-Daily, Oral Treatment for Relapsing Remitting Multiple Sclerosis
November 20, 2013
From PR Newswire
Clinical Trial Results, New Products, Employee Grants, Pricing of Offering - Research Report on GSK, Intuitive, IDEXX, Sanofi, and Foundation Medicine
November 19, 2013
From PR Newswire
Small step for BioMarin could mean leap for rare disease patients
November 18, 2013
From Business Journals
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.